900 Blake Wilbur Drive - First Floor
Stanford, CA 94305
Stanford Breast Cancer
At Stanford, our Breast Cancer physicians and researchers have been instrumental in developing many of the leading technologies used to diagnose and treat breast cancer today. Our program is a major referral center for patients across the country. This expertise allows us to offer you personalized treatment options based on the most recent clinical and research data available.
Stanford's Breast Cancer program is located in the new Women's Cancer Center, a warm and welcoming facility that unites clinicians, researchers and health care professionals in a nurturing environment. Program highlights include:
- Collaborative team-based care for each patient
- Superior diagnostic capabilities
- Advanced treatment options
- Extensive support services
- Integrated, innovative research to help improve our understanding of breast cancer, develop new tools for early detection, and create more effective treatments
Spotlight Videos
Anne Broderick's story
Stanford oncologist, Douglas Blayney, MD, discusses breast cancer
Breast cancer patient Anita Laughlin
Breast Cancer News
Dr. Mark Pegram joins Stanford Hospital & Clinics as the new head of the Breast Cancer Program. Read more about Dr. Pegram...»
Meet Our Physicians
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Breast Imaging Radiologist
-
Breast Imaging Radiologist
-
Breast Imaging Radiologist
-
Breast Imaging Radiologist
-
Breast Imaging Radiologist
-
Breast Imaging Radiologist
-
Breast Imaging Radiologist
Treatment & Research
As a patient at Stanford's Women's Cancer Center, you'll benefit from our integrated treatment programs. Read more »
Our breast cancer patients benefit from world-class research, and access to experimental therapies and clinical trials at Stanford.
Read more »
The BRCA Decision Tool guides the management of cancer risks for BRCA1 and BRCA2 mutation carriers, helping Melanie Lemons understand options and make critical decisions. Read more »
[ close x ]
Treatment options:
- Advanced diagnostic and imaging capabilities, including MRI-directed needle biopsies
- New surgical and radiation therapy treatments, such as single-dose intra-operative radiation therapy (IORT) or 3D conformal partial breast irradiation, which shorten treatment times and reduce exposure
- New drug therapies, including PARP inhibitors and immunotherapy
- Novel breast reconstruction techniques for patients who want options beyond implants
- Weekly tumor board of multidisciplinary experts review your same-day physical exam, records, radiographs and pathology results, and provide immediate treatment recommendations
- Support programs such as meditation and acupuncture to complement medical treatment; survivorship programs for the patient and family
[ close x ]
Clinical research:
- Stem cell research that may help early detection and treatment strategies, and predict reoccurrence
- Improved tumor classification that allows for more personalized treatment options
- Clinical trials with investigational therapies:
- PARP inhibitors, which may be used as preventive therapy for women with an inherited risk of breast cancer, as well as in combination with chemotherapy to maximize outcomes
- Vaccines to prevent HER2-positive breast cancer
- Immunotherapies that corral the immune system in fighting the disease
- Preventive strategies for women at increased risk of breast cancer based on computer modeling
- Improved visualization techniques for finding cancers in dense breast tissue
For a complete list of clinical trials, please click here »
Trial Administration